ArticleHepatic oncology2026
Characteristics of hepatocellular carcinoma in a Saudi tertiary care center: a 10-year retrospective study.
Article in Hepatic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo evaluate the clinical and pathological characteristics of hepatocellular carcinoma (HCC) diagnosed at a tertiary care center in Saudi Arabia over a 10-year period. MATERIALS AND
methodsThis retrospective observational study included 44 patients diagnosed with HCC between January 2014 and December 2023. Demographic data, risk factors, tumor characteristics, and histopathological findings were extracted from medical records and pathology reports.
resultsThe cohort showed a male predominance (77.3%), with a mean age of 65.8 years. Nearly half of patients (45.5%) had negative viral hepatitis tests. Vascular invasion and portal vein thrombosis occurred in 25.0% and 22.7%, respectively. The trabecular growth pattern predominated, and many patients presented with advanced disease features and substantial tumor burden.
conclusionHCC was frequently diagnosed at an advanced stage, with a substantial proportion of viral-negative cases. These exploratory findings are consistent with an evolving epidemiologic profile of HCC in Saudi Arabia but do not establish a causal relationship between metabolic factors and HCC. Despite its retrospective single-center design and small sample size, this study provides contemporary real-world data and highlights the need for improved surveillance, earlier detection, and larger multicenter studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.